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REPLY
We appreciate the interest of Dr. Freeman and her colleagues in
our recent publication on 22q11.2 microdeletion in adults (1). The
data they present are in keeping with the literature that indicates
certain conotruncal anomalies, such as pulmonary atresia/VSD, are
frequently associated with 22q11.2 microdeletion. Although the
patients who were positive for 22q11.2 microdeletion in their
center had “classic” features of the syndrome (two-thirds had
dysmorphic features and two-thirds significant developmental
delay), in our prospective cohort a significant proportion did not
have these findings. We would also like to remind the readership
that at the present time our position on screening adults is that it
should be individualized as opposed to mandatory. We believe
screening should be considered in patients with “high-risk” cardiac
lesions, or if there is the presence of specific clinical features that are
associated with 22q11.2 microdeletion as listed in our report (1). The
pros and cons of screening should be discussed with each patient so
that a decision, based on informed consent, can be made (2).
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CORRECTION
Costa RA,Mintz GS, Carlier SG, Lansky AJ,Moussa I, Fujii K, Takebayashi H, Yasuda T, Costa JR Jr., Tsuchiya Y, Jensen LO, Cristea
E, Mehran R, Dangas GD, Iyer S, Collins M, Kreps EM, Colombo A, Stone GW, LeonMB,Moses JW. Bifurcation Coronary Lesions
Treated With the “Crush” Technique: An Intravascular Ultrasound Analysis. J Am Coll Cardiol 2005;46:599–605.
In the opening paragraph of the article, the second sentence should read: “Regardless of the technique, restenosis rates after bare metal
stenting were high (40% to 60%), especially at the ostium of the side branch (SB) (1–3) where lesions frequently present with negative
remodeling before PCI and suboptimal angiographic results after PCI (1,4).”
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